In-vitro selection of porin-deficient mutants of two strains of Klebsiella pneumoniae with reduced susceptibilities to meropenem, but not to imipenem

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 6, 1998, Pages 821-824

  Pragai, Z ^a   Nagy, E ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM MUTANT; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS;

BETA-LACTAMASES; DRUG RESISTANCE, MICROBIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMIPENEM; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION; PORINS; THIENAMYCINS;

EID: 0032429707     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.6.821     Document Type: Article

References (13)

1. Martínez-Martínez, L., Hernandez-Alles, S., Albertí, S., Tomas, J. M., Benedi, V. J. & Jacoby, G. A. (1996). In vivo selection of porin-deficient mutants of Klebsiella pneumonias with increased resistance to cefoxitin and expanded-spectrum-cephalosporins. Antimicrobial Agents and Chemotherapy 40, 342-8.
2. Pangon, B., Bizet, C., Buré, A., Pichon, F., Philippon, A., Regnier, B. et al. (1989). In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 β-lactamase. Journal of Infectious Diseases 159, 1005-6.
3. Bradford, P. A., Urban, C., Mariano, N., Projan, S. J., Rahal, J. J. & Bush, K. (1997). Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrobial Agents and Chemotherapy 41, 563-9.
4. MacKenzie, F. M., Forbes, K. J., Dorai-John, T., Amyes, S. G. B. & Gould, I. M. (1997). Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet 350, 783.
5. Baker, C. N., Stocker, S. A., Culver, D. H. & Thornsberry, C. (1991). Comparison of the Etest to agar dilution, broth microdilution and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. Journal of Clinical Microbiology 29, 533-8.
6. National Committee for Clinical Laboratory Standards. (1995). Performance Standards for Antimicrobial Susceptibility Testing: Sixth Informational Supplement, Document M100-S6. NCCLS, Wayne, PA.
7. O'Callaghan, C. H., Morris, A., Kirby, S. M. & Shingler, A. H. (1972). Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrobial Agents and Chemotherapy 1, 283-8.
8. Lowry, O. H., Rosebrough, N. J., Farr, A. G. & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265-75.
9. M'Zali, F.-H., Gascoyne-Binzi, D. M., Heritage, J. & Hawkey, P. M. (1996). Detection of mutations conferring extended-spectrum activity on SHV β-lactamases using polymerase chain reaction single strand conformational polymorphism (PCR-SSCP). Journal of Antimicrobial Chemotherapy 37, 797-802.
10. Arlet, G. & Philippon, A. (1991). Construction by polymerase chain reaction and intragenic DNA hybridization for three main types of transferable β-lactamases (TEM, SHV, CARB). FEMS Microbiology Letters 82, 19-26.
11. Albertí, S., Rodríguez-Quinones, F., Schirmer, T., Rummel, G., Tomás, J. M., Rosenbusch, J. P. et al. (1995). A porin from Klebsiella pneumoniae: sequence homology, three dimensional structure, and complement binding. Infection and Immunity 63, 903-10.
12. Cornaglia, G., Russell, K., Satta, G. & Fontana, R. (1995). Relative importances of outer membrane permeability and group 1 β-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae. Antimicrobial Agents and Chemotherapy 39, 350-5.
13. Poole, K. (1994). Bacterial multidrug resistance - emphasis on efflux mechanisms and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 34, 453-6.